Erratum: TAR-200 for Bacillus Calmette-Guérin–Unresponsive High-Risk Non–Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study

Siamak Daneshmand

Department of Urology, Keck School of Medicine of University of Southern California, Norris Comprehensive Cancer Center

Michiel S. Van Der Heijden

Department of Medical Oncology Netherlands Cancer Institute Amsterdam Netherlands

Joseph M. Jacob

Department of Urology, SUNY Upstate Medical University, Syracuse, NY

Félix Guerrero-Ramos

Martin Bögemann

Department of Urology, Münster University Hospital, Münster, Germany

Giuseppe Simone

Department of Urology, 'Regina Elena' National Cancer Institute, Rome, Italy

Christopher M. Pieczonka

Clinical Research, U.S. Urology Partners and Associated Medical Professionals of New York, Syracuse

Nelson Canales Casco

Hospital de Jerez de la Frontera y Punta Europa, Cádiz, Spain

Daniel Zainfeld

Urology San Antonio, San Antonio, TX

Philipp Spiegelhalder

Urologie Neandertal, Gemeinschaftspraxis für Urologie, Mettmann, Germany

Evanguelos Xylinas

Department of Urology, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris Cité, Paris, France

David Cahn

Colorado Urology, Lakewood, CO

Yair Lotan

Department of Urology, UT Southwestern Medical Center, Dallas, TX

Katie S. Murray

Department of Urology, NYU Grossman School of Medicine, New York, NY

Takashi Kawahara

Katharine Stromberg

Johnson & Johnson, Raritan, NJ

Jason Martin

Abhijit Shukla

Johnson & Johnson, Lexington, MA

Christopher J. Cutie

Johnson & Johnson, Lexington, MA

Kristi Bertzos

Johnson & Johnson, Horsham, PA

Shalaka Hampras

Johnson & Johnson, Raritan, NJ

Hussein Sweiti

Johnson & Johnson, Spring House, PA

Andrea Necchi

Department of Medical Oncology Fondazione IRCCS Istituto Nazionale dei Tumori University of Milan Milan Italy